Trials In Focus: Allogene Off-The-Shelf Study Mirrors Earlier CAR-T Trials
Trial Design Draws Analyst Praise
In Scrip’s new column tracking clinical trial developments, NewAmsterdam, CatalYm, Verve, Bellerophon and Almirall announced new trials or changes to existing ones, while CROs Parexel and PPD announced new programs and CTI appointed a new exec.
